Blog

Global Think Tank on Steatotic Liver Disease

Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver...

MASLD and Type 2 Diabetes

An article recently published in Diabetes Care highlights the significant interplay between...

Improving QOL For Decompensated Cirrhosis Patients

Consider the article titled "Decompensated Liver Cirrhosis Care" from Gastroenterology &...

Telemedicine for HCV

Consider this 02/27/2025 article by Steve Bryson, PhD titled: "Hepatitis C telemedicine approach for opioid users receives award" is eye-opening-- "A program using a telemedicine approach to treat hepatitis C in people with opioid use disorder that resulted...

read more

MASLD Link to HF Risk

"Our study…demonstrate[s] an increased risk of HF in MASLD patients and suggests individuals with MASLD and a high metabolic burden should be vigilant about the potential development of HF."Conclusion from the 08 January 2025 study published in The European Journal of...

read more

Difference Makers in Hep: Blue Faery

Get to know Blue Faery: The Adrienne Wilson Liver Cancer Association - their mission is to prevent, treat and cure primary liver cancer, specifically Hepatocellular Carcinoma ("HCC"), through research, education, and advocacy."Did you know? Over 905,677 people are...

read more

Follow Us

© Copyright 2025 LiverRight - All Rights Reserved - Cincinnati, Ohio & London, Kentucky